A monoclonal gammopathy precedes multiple myeloma in most patients (Q37209020)

19 August 2017

A monoclonal gammopathy precedes multiple myeloma in most patients (English)

1 reference

19 August 2017

0 references

1 reference

Brendan M Weiss

1

1 reference

19 August 2017

Jude Abadie

2

1 reference

19 August 2017

Pramvir Verma

3

1 reference

19 August 2017

Robin S Howard

4

1 reference

19 August 2017

W Michael Kuehl

5

1 reference

19 August 2017

language of work or name

English

0 references

publication date

20 February 2009

1 reference

19 August 2017

5

1 reference

inferred from page(s)

published in

Blood

1 reference

19 August 2017

113

1 reference

19 August 2017

22

1 reference

19 August 2017

5418-5422

1 reference

19 August 2017

Cancer statistics, 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689043

Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689043

New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689043

Clinical practice. Monoclonal gammopathy of undetermined significance

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689043

Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689043

Prevalence of monoclonal gammopathy of undetermined significance

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689043

Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689043

Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689043

Review of 1027 patients with newly diagnosed multiple myeloma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689043

Multiple myeloma: evolving genetic events and host interactions

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689043

Pathophysiology of the monoclonal gammopathies.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689043

Outcome after autologous stem cell transplantation for multiple myeloma in patients with preceding plasma cell disorders.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689043

A long-term study of prognosis in monoclonal gammopathy of undetermined significance.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689043

Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma. Intergroupe Francophone du Myélome.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689043

Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689043

Complete response in myeloma extends survival without, but not with history of prior monoclonal gammopathy of undetermined significance or smouldering disease

4 December 2018

1 reference

12 December 2020

IgD monoclonal gammopathy of undetermined significance

1 reference

12 December 2020

Monoclonal gammopathy of undetermined significance (MGUS)-31 year follow up of a community study

1 reference

12 December 2020

Genomic abnormalities in monoclonal gammopathy of undetermined significance

1 reference

12 December 2020

The Defense Medical Surveillance System and the Department of Defense serum repository: glimpses of the future of public health surveillance

1 reference

12 December 2020

Immunoglobulin D multiple myeloma: presenting features, response to therapy, and survival in a series of 53 cases

1 reference

12 December 2020

IgD monoclonal gammopathy with long-term follow-up

1 reference

12 December 2020

10.1182/BLOOD-2008-12-195008

Identifiers

DOI

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

19234139

1 reference